About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 373426, 5 pages
http://dx.doi.org/10.1155/2010/373426
Research Article

High-Sensitivity C-Reactive Protein: An Independent Risk Factor for Left Ventricular Hypertrophy in Patients with Lupus Nephritis

Renal Division, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road, Shanghai 200127, China

Received 16 March 2010; Revised 7 July 2010; Accepted 14 October 2010

Academic Editor: J. W. Tervaert

Copyright © 2010 Beili Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Omdal, P. Lunde, K. Rasmussen, S. I. Mellgren, and G. Husby, “Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus,” Scandinavian Journal of Rheumatology, vol. 30, no. 5, pp. 275–281, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Pieretti, M. J. Roman, and M. J. Roman, “Systemic lupus erythematosus predicts increased left ventricular mass,” Circulation, vol. 116, no. 4, pp. 419–426, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Naarendorp, L. D. Kerr, A. S. Khan, and M. H. Ornstein, “Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases,” Journal of Rheumatology, vol. 26, no. 10, pp. 2257–2260, 1999. View at Scopus
  4. P. M. Ridker, “High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease,” Circulation, vol. 103, no. 13, pp. 1813–1818, 2001. View at Scopus
  5. N. S. Rost, P. A. Wolf, and P. A. Wolf, “Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study,” Stroke, vol. 32, no. 11, pp. 2575–2579, 2001. View at Scopus
  6. W. Koenig, M. Sund, and M. Sund, “C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992,” Circulation, vol. 99, no. 2, pp. 237–242, 1999. View at Scopus
  7. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Scopus
  8. Y. Iwashima, T. Horio, K. Kamide, H. Rakugi, T. Ogihara, and Y. Kawano, “C-reactive protein, left ventricular mass index and risk of cardiovascular disease in essential hypertension,” Hypertension Research, vol. 30, no. 12, pp. 1177–1185, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. B.-S. Kim, S. J. Doo, and S. J. Doo, “Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis,” American Journal of Nephrology, vol. 25, no. 3, pp. 189–195, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. M. Tan, A. S. Cohen, and J. F. Fries, “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Scopus
  11. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Scopus
  12. A. Levin, J. Singer, C. R. Thompson, H. Ross, and M. Lewis, “Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention,” American Journal of Kidney Diseases, vol. 27, no. 3, pp. 347–354, 1996. View at Scopus
  13. T. A. Pearson, G. A. Mensah, and G. A. Mensah, “Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association,” Circulation, vol. 107, no. 3, pp. 499–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Weening, V. D. D'Agati, and V. D. D'Agati, “The classification of glomerulonephritis in systemic lupus erythematosus revisited,” Kidney International, vol. 65, no. 2, pp. 521–530, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. B.-S. Kim, S. J. Doo, and S. J. Doo, “Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis,” American Journal of Nephrology, vol. 25, no. 3, pp. 189–195, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. K. Yasunari, K. Maeda, T. Watanabe, M. Nakamura, J. Yoshikawa, and A. Asada, “Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy,” Journal of the American College of Cardiology, vol. 43, no. 11, pp. 2116–2123, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Scopus
  18. Y. Saijo, E. Yoshioka, T. Fukui, M. Kawaharada, and R. Kishi, “Metabolic syndrome, C-reactive protein and increased arterial stiffness in Japanese subjects,” Hypertension Research, vol. 29, no. 8, pp. 589–596, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. Frohlich, A. Imhof, G. Berg, et al., “Association between Creactive protein and features of the metabolic syndrome: a population-based study,” Diabetes Care, vol. 23, pp. 1835–1839, 2000.
  20. E. S. Ford, “Body mass index, diabetes, and C-reactive protein among U.S. Adults,” Diabetes Care, vol. 22, no. 12, pp. 1971–1977, 1999. View at Scopus
  21. G. J. Blake, N. Rifai, J. E. Buring, and P. M. Ridker, “Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events,” Circulation, vol. 108, no. 24, pp. 2993–2999, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. I. Jialal, S. Devaraj, and S. K. Venugopal, “C-reactive protein: risk marker or mediator in atherothrombosis?” Hypertension, vol. 44, no. 1, pp. 6–11, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. W. Zhong, Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R. F. Mortensen, “Effect of human C-reactive protein on chemokine and chemotactic factor- induced neutrophil chemotaxis and signaling,” Journal of Immunology, vol. 161, no. 5, pp. 2533–2540, 1998. View at Scopus
  24. S. Verma, C.-H. Wang, and C.-H. Wang, “A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis,” Circulation, vol. 106, no. 8, pp. 913–919, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal, “Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells,” Circulation, vol. 106, no. 12, pp. 1439–1441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. P. Mazer and L. E. Rabbani, “Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP,” Journal of Thrombosis and Thrombolysis, vol. 17, no. 2, pp. 95–105, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. J. Bisoendial, J. J. P. Kastelein, and J. J. P. Kastelein, “Activation of inflammation and coagulation after infusion of C-reactive protein in humans,” Circulation Research, vol. 96, no. 7, pp. 714–716, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus